Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

FPHAX

Fidelity Select Pharmaceuticals

FPHAX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

FPHAX Analyst Rating

Strong Buy

52 Buy

7 Hold

1 Sell

Based on the consensus analyst ratings on 60 stocks held in FPHAX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

FPHAX Analyst Price Target

Average Price Target

$36.15

Based on 60 Wall Street analysts offering 12 month price targets to Fidelity Select Pharmaceuticals holdings in the last 3 months. The average price target is $36.15 with a high forecast of $44.24 and a low forecast of $27.65. The average price target represents a 21.59% change from the last price of $29.73.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"21":"$21","27":"$27","33":"$33","39":"$39","45":"$45"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":44.243,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$44.24</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36.15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$36.15</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27.647,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$27.65</span>\n  </div></div>","useHTML":true}}],"tickPositions":[21,27,33,39,45],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2023","6":"Jan<br/>2024","9":"Apr<br/>2024","12":"Jul<br/>2024","25":"Jul<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.83,30.938692307692307,32.047384615384615,33.156076923076924,34.26476923076923,35.37346153846154,36.48215384615385,37.59084615384616,38.69953846153847,39.808230769230775,40.916923076923084,42.025615384615385,43.134307692307694,{"y":44.243,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.83,30.316153846153846,30.80230769230769,31.288461538461537,31.774615384615384,32.26076923076923,32.746923076923075,33.23307692307692,33.71923076923077,34.20538461538462,34.69153846153846,35.177692307692304,35.66384615384615,{"y":36.15,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.83,29.66207692307692,29.494153846153843,29.32623076923077,29.15830769230769,28.990384615384613,28.822461538461535,28.65453846153846,28.486615384615384,28.318692307692306,28.150769230769228,27.982846153846154,27.814923076923076,{"y":27.647,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":23.02,"date":1688342400000,"info":"<div>Price: <b>$23<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.13,"date":1690848000000,"info":"<div>Price: <b>$23<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.22,"date":1693526400000,"info":"<div>Price: <b>$24<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.7,"date":1696204800000,"info":"<div>Price: <b>$23<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.14,"date":1698796800000,"info":"<div>Price: <b>$22<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.08,"date":1701388800000,"info":"<div>Price: <b>$23<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.84,"date":1704153600000,"info":"<div>Price: <b>$24<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.21,"date":1706745600000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.56,"date":1709251200000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.64,"date":1711929600000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.36,"date":1714521600000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.74,"date":1717372800000,"info":"<div>Price: <b>$29<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.83,"date":1719792000000,"info":"<div>Price: <b>$30<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$44.24

Average Price Target$36.15

Lowest Price Target$27.65

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

FPHAX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

SLRN

ACELYRIN, INC.

―

4 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

BLUE

Bluebird bio Inc

―

3 Buy

3 Hold

1 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GLUE

Monte Rosa Therapeutics, Inc.

―

5 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

PRTA

Prothena Corporation

―

5 Buy

1 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ANNX

Annexon Biosciences, Inc.

―

6 Buy

0 Hold

0 Sell

Strong Buy

―

FPHAX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

IBAB

Ion Beam Applications SA IBA

―

0 Buy

0 Hold

1 Sell

Moderate Sell

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

AGL

Agilon Health Inc

―

5 Buy

9 Hold

1 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

SDZNY

Sandoz Group Ltd Sponsored ADR

―

2 Buy

1 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

DYN

Dyne Therapeutics, Inc.

―

9 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

BMY

Bristol-Myers Squibb Company

―

3 Buy

8 Hold

3 Sell

Hold

―

FPHAX Mutual Fund FAQ

What is FPHAX’s average 12-month price target, according to analysts?

Based on analyst ratings, Fidelity Select Pharmaceuticals’s 12-month average price target is $36.15.

What is FPHAX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for FPHAX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is FPHAX a Buy, Sell or Hold?

Fidelity Select Pharmaceuticals has a consensus rating of Strong Buy which is based on 52 buy ratings, 7 hold ratings and 1 sell ratings.

What is Fidelity Select Pharmaceuticals’s price target?

The average price target for Fidelity Select Pharmaceuticals is $36.15. This is based on 60 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $44.24 ,the lowest forecast is $27.65. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about Fidelity Select Pharmaceuticals?

Fidelity Select Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 60 Wall Streets Analysts.

How can I buy shares of FPHAX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing